How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/cesarean-section-infection-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cesarean Section Infection Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cesarean Section Infection Prevention (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Cesarean Section Infection Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Claforan	CEFOTAXIME	Sterimax	Cephalosporin Antibacterial			1981-01-01
Unasyn	AMPICILLIN	Bristol-Myers Squibb	Penicillin-class Antibacterial	Transient receptor potential cation channel subfamily M member 4		1965-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Cesarean Section Infection Prevention
Bristol-Myers Squibb · 1 drug in Cesarean Section Infection Prevention
Sterimax · 1 drug in Cesarean Section Infection Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Cesarean Section Infection Prevention:

Cite this brief

Drug Landscape (2026). Cesarean Section Infection Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/cesarean-section-infection-prevention. Accessed 2026-06-10.

Cesarean Section Infection Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing